PURPOSE: Carnosine is a dipeptide composed of β-alanine and L-histidine and is present in skeletal muscle. Chronic oral β-alanine supplementation can induce muscle carnosine loading and is therefore seen as the rate-limiting factor for carnosine synthesis. However, the effect of L-histidine supplementation on carnosine levels in humans is never established. This study aims to investigate whether 1) L-histidine supplementation can induce muscle carnosine loading and 2) combined supplementation of both amino acids is more efficient than β-alanine supplementation alone. METHODS:Fifteen male and 15 female participants were equally divided in three groups. Each group was supplemented with either pure β-alanine (BA) (6 g·d), L-histidine (HIS) (3.5 g·d), or both amino acids (BA + HIS). Before (D0), after 12 d (D12), and after 23 d (D23) of supplementation, carnosine content was evaluated in soleus and gastrocnemius medialis muscles by H-MRS, and venous blood samples were collected. Muscle biopsies were taken at D0 and D23 from the vastus lateralis. Plasma and muscle metabolites (β-alanine, histidine, and carnosine) were measured by high-performance liquid chromatography. RESULTS: Both BA and BA + HIS groups showed increased carnosine concentrations in all investigated muscles, with no difference between these groups. By contrast, carnosine levels in the HIS group remained unaltered. Histidine levels were significantly decreased in plasma (-30.6%) and muscle (-31.6%) of the BA group, and this was prevented when β-alanine and L-histidine were supplemented simultaneously. CONCLUSION: We confirm that β-alanine, and not L-histidine, is the rate-limiting precursor for carnosine synthesis in human skeletal muscle. Yet, although L-histidine is not rate limiting, its availability is not unlimited and gradually declines upon chronic β-alanine supplementation. The significance of this decline still needs to be determined, but may affect physiological processes such as protein synthesis.
RCT Entities:
PURPOSE: Carnosine is a dipeptide composed of β-alanine and L-histidine and is present in skeletal muscle. Chronic oral β-alanine supplementation can induce muscle carnosine loading and is therefore seen as the rate-limiting factor for carnosine synthesis. However, the effect of L-histidine supplementation on carnosine levels in humans is never established. This study aims to investigate whether 1) L-histidine supplementation can induce muscle carnosine loading and 2) combined supplementation of both amino acids is more efficient than β-alanine supplementation alone. METHODS: Fifteen male and 15 female participants were equally divided in three groups. Each group was supplemented with either pure β-alanine (BA) (6 g·d), L-histidine (HIS) (3.5 g·d), or both amino acids (BA + HIS). Before (D0), after 12 d (D12), and after 23 d (D23) of supplementation, carnosine content was evaluated in soleus and gastrocnemius medialis muscles by H-MRS, and venous blood samples were collected. Muscle biopsies were taken at D0 and D23 from the vastus lateralis. Plasma and muscle metabolites (β-alanine, histidine, and carnosine) were measured by high-performance liquid chromatography. RESULTS: Both BA and BA + HIS groups showed increased carnosine concentrations in all investigated muscles, with no difference between these groups. By contrast, carnosine levels in the HIS group remained unaltered. Histidine levels were significantly decreased in plasma (-30.6%) and muscle (-31.6%) of the BA group, and this was prevented when β-alanine and L-histidine were supplemented simultaneously. CONCLUSION: We confirm that β-alanine, and not L-histidine, is the rate-limiting precursor for carnosine synthesis in human skeletal muscle. Yet, although L-histidine is not rate limiting, its availability is not unlimited and gradually declines upon chronic β-alanine supplementation. The significance of this decline still needs to be determined, but may affect physiological processes such as protein synthesis.
Authors: Bryan Saunders; Mariana Franchi; Luana Farias de Oliveira; Vinicius da Eira Silva; Rafael Pires da Silva; Vitor de Salles Painelli; Luiz Augusto Riani Costa; Craig Sale; Roger Charles Harris; Hamilton Roschel; Guilherme Giannini Artioli; Bruno Gualano Journal: Eur J Nutr Date: 2018-12-14 Impact factor: 5.614
Authors: Richard R Lobo; Banny S B Correia; Yuli A Peña-Bermúdez; Rafaela Vincenzi; Caroline M da Silva; Leticia L Panosso; Caroline Ceribeli; Luiz A Colnago; Daniel R Cardoso; Alexandre Berndt; Rafael S B Pinheiro; Ives C da S Bueno; Antonio P Faciola Journal: J Anim Sci Date: 2021-09-01 Impact factor: 3.338
Authors: Roy Meys; Anouk A F Stoffels; Jana de Brandt; Hieronymus W H van Hees; Frits M E Franssen; Maurice J H Sillen; Emiel F M Wouters; Chris Burtin; Peter Klijn; Eline Bij de Vaate; Bram van den Borst; Jacqueline M Otker; Jos Donkers; Florence N Schleich; Maurice Hayot; Pascal Pomiès; Inge Everaert; Wim Derave; Martijn A Spruit Journal: BMJ Open Date: 2020-09-13 Impact factor: 2.692
Authors: Assis Moreira João Pedro; Thais Melo Marques; Ludmila Dias dos Santos Leal; Paula Souza Alves Santos; Joao Pedro de Souza Ferreira; Raul Dominguez; Sandro Fernandes da Silva; David A Story; Harry B Rossiter; Richard M Effros; Johan M van Schalkwyk Journal: J Appl Physiol (1985) Date: 2021-06-01
Authors: Matthew I Black; Andrew M Jones; Paul T Morgan; Stephen J Bailey; Jonathan Fulford; Anni Vanhatalo Journal: Front Physiol Date: 2018-02-21 Impact factor: 4.566
Authors: José Luis Maté-Muñoz; Juan H Lougedo; Manuel V Garnacho-Castaño; Pablo Veiga-Herreros; María Del Carmen Lozano-Estevan; Pablo García-Fernández; Fernando de Jesús; Jesús Guodemar-Pérez; Alejandro F San Juan; Raúl Domínguez Journal: J Int Soc Sports Nutr Date: 2018-04-25 Impact factor: 5.150